| Literature DB >> 35445721 |
Eiichi Tanaka1,2, Eisuke Inoue1,3, Mai Abe1,2, Kumiko Saka1,2, Eri Sugano1,2, Moeko Ochiai1,2, Rei Yamaguchi1,2, Katsunori Ikari2,4,5, Hisashi Yamanaka1,6,7, Masayoshi Harigai1,2.
Abstract
Entities:
Keywords: COVID-19; adherence; biological disease-modifying antirheumatic drugs; methotrexate; pandemic; rheumatoid arthritis
Mesh:
Substances:
Year: 2022 PMID: 35445721 PMCID: PMC9047218 DOI: 10.1093/mr/roab120
Source DB: PubMed Journal: Mod Rheumatol ISSN: 1439-7595 Impact factor: 2.862